Genetic, cell biological and clinical interrogation of the CFTR mutation c.3700 A>G (p.Ile1234Val) informs strategies for future medical intervention
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic, cell biological and clinical interrogation of the CFTR mutation c.3700 A>G (p.Ile1234Val) informs strategies for future medical intervention
Authors
Keywords
-
Journal
GENETICS IN MEDICINE
Volume 16, Issue 8, Pages 625-632
Publisher
Springer Nature
Online
2014-02-21
DOI
10.1038/gim.2014.4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with aG551DMutation
- (2013) Jane C. Davies et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Genetic Modifiers of Cystic Fibrosis-Related Diabetes
- (2013) S. M. Blackman et al. DIABETES
- VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1
- (2013) Hong Yu Ren et al. MOLECULAR BIOLOGY OF THE CELL
- Mechanism-based corrector combination restores ΔF508-CFTR folding and function
- (2013) Tsukasa Okiyoneda et al. Nature Chemical Biology
- Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
- (2013) Patrick R Sosnay et al. NATURE GENETICS
- Vx-770 potentiates CFTR function by promoting decoupling between the gating cycle and ATP hydrolysis cycle
- (2013) Kang-Yang Jih et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ivacaftor treatment of cystic fibrosis patients with the G551D mutation: a review of the evidence
- (2013) Kavitha Kotha et al. Therapeutic Advances in Respiratory Disease
- β-Adrenergic Sweat Secretion as a Diagnostic Test for Cystic Fibrosis
- (2012) Paul Quinton et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator VX-770 (Ivacaftor) Opens the Defective Channel Gate of Mutant CFTR in a Phosphorylation-dependent but ATP-independent Manner
- (2012) Paul D. W. Eckford et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein
- (2012) Amy P Wong et al. NATURE BIOTECHNOLOGY
- Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis
- (2012) Lei Sun et al. NATURE GENETICS
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
- (2011) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for theF508del-CFTRmutation
- (2011) J P Clancy et al. THORAX
- The Cystic Fibrosis-causing Mutation ΔF508 Affects Multiple Steps in Cystic Fibrosis Transmembrane Conductance Regulator Biogenesis
- (2010) Patrick H. Thibodeau et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Update in Cystic Fibrosis 2008
- (2009) Felix Ratjen AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
- (2009) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus Report
- (2008) Philip M. Farrell et al. JOURNAL OF PEDIATRICS
- Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function
- (2008) A. W. R. Serohijos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now